Beskrivelse
Krav
Fullmektig i Norge:
Org.nummer: 925400262
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2010.05.14, US 39565210 P
BROWN E ET AL: "Integrin-associated protein: A 50-kD plasma membrane antigen physically and functionally associated with integrins", THE JOURNAL OF CELL BIOLOGY : JCB, THE ROCKEFELLER UNIVERSITY PRESS, US, vol. 111, no. 6, PART 01, 1 December 1990 (1990-12-01), pages 2785-2794, XP002105095, ISSN: 0021-9525, DOI: 10.1083/JCB.111.6.2785 (B1)
H. D. GRESHAM: "A novel member of the integrin receptor family mediates Arg-Gly-Asp- stimulated neutrophil phagocytosis", THE JOURNAL OF CELL BIOLOGY, vol. 108, no. 5, 1 May 1989 (1989-05-01), pages 1935-1943, XP055163826, ISSN: 0021-9525, DOI: 10.1083/jcb.108.5.1935 (B1)
LINDBERG F P ET AL: "MOLECULAR CLONING OF INTEGRIN-ASSOCIATED PROTEIN: AN IMMUNOGLOBULINFAMILY MEMBER WITH MULTIPLE MEMBRANE-SPANNING DOMAINS IMPLICATED INALPHAVBETA3-DEPENDENT LIGAND BINDING", THE JOURNAL OF CELL BIOLOGY : JCB, THE ROCKEFELLER UNIVERSITY PRESS, US, vol. 123, no. 2, 1 October 1993 (1993-10-01), pages 485-496, XP002929109, ISSN: 0021-9525, DOI: 10.1083/JCB.123.2.485 (B1)
PETTERSEN R F ET AL: "CD47 SIGNALS T CELL DEATH", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 162, 1 January 1999 (1999-01-01), pages 7031-7040, XP002940659, ISSN: 0022-1767 (B1)
RAVINDRA MAJETI1 ET AL: "CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells", DEVELOPMENTAL CELL, CELL PRESS, CAMBRIDGE, MA, US, vol. 138, no. 2, 23 July 2009 (2009-07-23) , pages 286-299, XP002632714, ISSN: 1097-4172, DOI: 10.1016/J.CELL.2009.05.045 [retrieved on 2009-07-23] (B1)
WO-A1-2008/035894 (B1)
SUBRAMANIAN S ET AL: "Membrane mobility and clustering of Integrin Associated Protein (IAP, CD47)-Major differences between mouse and man and implications for signaling", BLOOD CELLS, MOLECULES AND DISEASES, LAJOLLA, US, vol. 36, no. 3, 6 May 2006 (2006-05-06), pages 364-372, XP024917773, ISSN: 1079-9796, DOI: 10.1016/J.BCMD.2006.01.012 [retrieved on 2006-05-06] (B1)
SUBRAMANIAN S ET AL: "The 'metabolon', CD47, and the 'phagocytic synapse': molecular co-localization and species divergence", TRANSFUSION CLINIQUE ET BIOLOGIQUE, ARNETTE-BLACKWELL, PARIS, FR, vol. 13, no. 1-2, 1 March 2006 (2006-03-01), pages 31-38, XP028032797, ISSN: 1246-7820, DOI: 10.1016/J.TRACLI.2006.02.009 [retrieved on 2006-03-01] (B1)
US-A1- 2003 108 546 (B1)
US-A1- 2008 107 654 (B1)
SELLI C ET AL: "Asynchronous bilateral non-Hodgkin's lymphoma of the testis: Report of three cases", UROLOGY, BELLE MEAD, NJ, US, vol. 44, no. 6, 1 December 1994 (1994-12-01), pages 930-932, XP023311276, ISSN: 0090-4295, DOI: 10.1016/S0090-4295(94)80188-6 [retrieved on 1994-12-01] (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3789038)
|
Utgående
EP Registreringsbrev (3210) (PTEP3789038)
|
Innkommende, AR512855164
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 15. avg. år (EP) expand_more expand_less | 2025.05.09 | 6310,0 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 15. avg. år (EP)
6310,0 = 1 X 6310,0
En ordre på saken er opprettet av: Supplier Payments (08.05.2025 07:06:25): Betalt |
||||
Årsavgift 14. avg. år (EP) | 2024.05.08 | 5850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2023.05.10 | 4200 | CPA GLOBAL LIMITED | Betalt og godkjent |
32214243 expand_more expand_less | 2022.11.18 | 5500 | AWA NORWAY AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|